Search - Université de Rennes Access content directly

Filter your results

85 Results
Author: personID (integer) : 767105

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies.

Holbrook E. Kohrt , Roch Houot , Matthew J. Goldstein , Kipp Weiskopf , Ash A. Alizadeh et al.
Blood, 2011, 117 (8), pp.2423-32. ⟨10.1182/blood-2010-08-301945⟩
Journal articles hal-00743985v1

Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapy.

Roch Houot , Holbrook E. Kohrt , Aurélien Marabelle , Ronald Levy
Trends in Immunology, 2011, 32 (11), pp.510-6. ⟨10.1016/⟩
Journal articles istex hal-00744044v1

Overcoming Intrinsic Resistance of Cancer Cells to CAR T-Cell Killing

Jean Lemoine , Marco Ruella , Roch Houot
Clinical Cancer Research, 2021, 27 (23), pp.6298-6306. ⟨10.1158/1078-0432.CCR-21-1559⟩
Journal articles hal-03367643v1
Image document

Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma

Simon Le Gallou , Faustine Lhomme , Jonathan M Irish , Anna Mingam , Celine Pangault et al.
Frontiers in Immunology, 2021, 12, pp.755623. ⟨10.3389/fimmu.2021.755623⟩
Journal articles hal-03531047v1
Image document

The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies

Hermann Einsele , Javier Briones , Fabio Ciceri , Irene García Cadenas , Fred Falkenburg et al.
HemaSphere, 2021, 5 (10), pp.e642. ⟨10.1097/HS9.0000000000000642⟩
Journal articles hal-03367656v1

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma

Steven Le Gouill , Catherine Thieblemont , Lucie Oberic , Anne Moreau , Krimo Bouabdallah et al.
New England Journal of Medicine, 2017, 377 (13), pp.1250-1260. ⟨10.1056/NEJMoa1701769⟩
Journal articles hal-02329536v1

Detection of clonal heterogeneity and targetable mutations in myeloid sarcoma by high-throughput sequencing.

Cedric Pastoret , Roch Houot , Francisco Llamas-Gutierrez , Marie-Laure Boulland , Tony Marchand et al.
Leukemia & lymphoma, 2017, 58 (4), pp.1008-1012. ⟨10.1080/10428194.2016.1225208⟩
Journal articles hal-01475955v1

Abstract 2466: Sequential tumor and immune targeted immunotherapy: Anti-tumor activity of antibody drug conjugate Trastuzumab Emtansine (T-DM1) with CD137 stimulation in HER-2+ breast cancer therapy

Suparna Dutt , Narendiran Rajasekaran , Aurelien Marabelle , Roch Houot , Mohith Sadaram et al.
Cancer Research, 2015, 75 (15 Supplement), pp.2466--2466. ⟨10.1158/1538-7445.AM2015-2466⟩
Journal articles hal-01300810v1

Nivolumab Is Effective and Reasonably Safe in Relapsed or Refractory Hodgkin's Lymphoma after Allogeneic Hematopoietic Cell Transplantation: A Study from the Lysa and SFGM-TC

Loic Ysebaert , Roch Houot , Ibrahim Yakoub-Agha , Franck Morschhauser , Charles Herbaux et al.
Blood, 2015, 126 (23), pp.3979-3979
Journal articles hal-01290424v1

A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study

Karim Labreche , Mailys Daniau , Amit Sud , Philip J Law , Louis Royer-Perron et al.
Neuro-Oncology, 2019, 21 (8), pp.1039-1048. ⟨10.1093/neuonc/noz088⟩
Journal articles hal-02328989v1
Image document

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies

Hermann Einsele , Javier Briones , Fabio Ciceri , Irene García-Cadenas , Fred Falkenburg et al.
HemaSphere, 2020, 4 (4), pp.e423. ⟨10.1097/HS9.0000000000000423⟩
Journal articles hal-03012806v1

Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumors

Cariad Chester , Aurelien Marabelle , Roch Houot , Holbrook E Kohrt
Current Opinion in Immunology, 2015, Lymphocyte development and activation * Tumour immunology, 33, pp.1-8. ⟨10.1016/j.coi.2014.12.010⟩
Journal articles hal-01104938v1

A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma

Bertrand Coiffier , Catherine Thieblemont , Sophie de Guibert , Jehan Dupuis , Vincent Ribrag et al.
British Journal of Haematology, 2016, 173 (5), pp.722-730. ⟨10.1111/bjh.13992⟩
Journal articles hal-01295660v1
Image document

CAR T-cells for T-cell malignancies challenges in distinguishing between therapeutic, normal, and neoplastic T-cells

Marion Alcantara , Melania Tesio , Carl H June , Roch Houot
Leukemia, 2018, 32 (11), pp.2307-2315. ⟨10.1038/s41375-018-0285-8⟩
Journal articles hal-01903063v1
Image document

Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA)

Guillaume Manson , Charles Herbaux , Jean Marc Schiano de Colella , René-Olivier Casasnovas , Aspasia Stamatoullas et al.
British Journal of Haematology, 2022, 198 (1), pp.203-206. ⟨10.1111/bjh.18198⟩
Journal articles hal-03665134v1
Image document

Interpretation of 2-[F-18]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors

Guillaume Manson , Amaeshi Chukwunonye Lemchukwu , Fatima-Zohra Mokrane , Egesta Lopci , Nicolas Aide et al.
European Radiology, 2022, 32, pp.6536-6544. ⟨10.1007/s00330-022-08669-8⟩
Journal articles hal-03665222v1

A dose-escalation study of SAR3419, an anti-CD19 antibody maytansinoid conjugate, administered by intravenous infusion once weekly in patients with relapsed/refractory B-cell non-Hodgkin lymphoma

Vincent Ribrag , Jehan Dupuis , Herve Tilly , Franck Morschhauser , Fabrice Laine et al.
Clinical Cancer Research, 2014, 20 (1), pp.213--220. ⟨10.1158/1078-0432.CCR-13-0580⟩
Journal articles hal-01068681v1

Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS.

Roch Houot , Steven Le Gouill , Mario Ojeda Uribe , C. Mounier , Stéphane Courby et al.
Annals of Oncology, 2012, 23 (6), pp.1555-61. ⟨10.1093/annonc/mdr450⟩
Journal articles hal-00744066v1

Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network

Sophie Langner-Lemercier , Caroline Houillier , Carole Soussain , Hervé Ghesquières , Olivier Chinot et al.
Neuro-Oncology, 2016, 18 (9), pp.1297-1303. ⟨10.1093/neuonc/now033⟩
Journal articles hal-01290413v1

Management and outcome of primary CNS lymphoma in the modern era: An LOC network study

Caroline Houillier , Carole Soussain , Hervé Ghesquières , Pierre Soubeyran , Olivier Chinot et al.
Neurology, 2020, 94 (10), pp.e1027-e1039. ⟨10.1212/WNL.0000000000008900⟩
Journal articles hal-02442415v1
Image document

Ovarian response to stimulation for fertility preservation in women with hematologic cancer

Tiffany Brun , Ludivine Dion , Sylvie Jaillard , Diane Bales , Mathilde Domin et al.
Journal of Gynecology Obstetrics and Human Reproduction, 2021, 50 (5), pp.101925. ⟨10.1016/j.jogoh.2020.101925⟩
Journal articles hal-02964534v1
Image document

Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation

Guillaume Manson , Jean-Baptiste Mear , Charles Herbaux , Jean-Marc Schiano , Olivier Casasnovas et al.
European Journal of Cancer, 2019, 115, pp.47-56. ⟨10.1016/j.ejca.2019.04.006⟩
Journal articles hal-02134578v1

Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma

Ahmad S. Halwani , Carlos Panizo , Iris Isufi , Alex F. Herrera , Craig Y. Okada et al.
Leukemia & lymphoma, 2021, ⟨10.1080/10428194.2021.2010057⟩
Journal articles hal-03519467v1

Immunothérapie des lymphomes diffus à grandes cellules B chimioréfractaires ou en rechute postautogreffe

Jean Lemoine , Roch Houot
Hématologie, 2021, 27 (S1), pp.26-36. ⟨10.1684/hma.2021.1625⟩
Journal articles hal-03281605v1

Checkpoint blockade after kidney transplantation

Mathieu Lesouhaitier , Caroline Dudreuilh , Mathilde Tamain , Nada Kanaan , Elodie Bailly et al.
European Journal of Cancer, 2018, 96, pp.111-114. ⟨10.1016/j.ejca.2018.03.019⟩
Journal articles hal-01795812v1

Performance of CT Compared with F-FDG PET in Predicting the Efficacy of Nivolumab in Relapsed or Refractory Hodgkin Lymphoma

Fatima-Zohra Mokrane , Aiping Chen , Lawrence H Schwartz , Franck Morschhauser , Apasia Stamatoullas et al.
Radiology, 2020, 295 (3), pp.651-661. ⟨10.1148/radiol.2020192056⟩
Journal articles hal-02569415v1

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma

Roch Houot , Tony Marchand , Nathalie Dhédin , Willy Lescaut , Anne Thiebaut-Bertrand et al.
Blood, 2017, 129 (10), pp.1380-1388. ⟨10.1182/blood-2016-09-738385⟩
Journal articles hal-01517054v1

Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study.

Emilie Reboursiere , Fabien Le Bras , Charles Herbaux , Emmanuel Gyan , Aline Clavert et al.
Oncotarget, 2016, 7 (51), pp.85573-85583. ⟨10.18632/oncotarget.10764⟩
Journal articles hal-01475957v1
Image document

Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.

June H. Myklebust , Joshua Brody , Holbrook E. Kohrt , Arne Kolstad , Debra K. Czerwinski et al.
Blood, 2017, 129 (6), pp.759-770. ⟨10.1182/blood-2016-05-718494⟩
Journal articles hal-01475956v1

T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition

Roch Houot , Liora Michal Schultz , Aurelien Marabelle , Holbrook Kohrt
Cancer Immunology Research, 2015, 3 (10), pp.1115--1122. ⟨10.1158/2326-6066.CIR-15-0190⟩
Journal articles hal-01216199v1